3 Buy-and-Hold Stocks Long-Term Investors Can Love in Any Market For buy-and-hold investors looking for some quality names to navigate a turbulent market, here are three stocks to consider
Apple, Nvidia, GM: CEOs Are Talking About Being American-Made Again US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys. Detroit & beyond are benefiting from this trend.
Meet the Warren Buffett Investment That's Gained 5,502,284% and Looks Set to Soar Even Higher Warren Buffett has had a lot of successful investments, but one in particular has crushed the stock market time and again.
US-China Trade Truce, Trump's Middle East Deals Spark Wall Street Rally: This Week In Markets U.S. and China cut tariffs by 115 points, sparking a stock rally and improving trade outlook. Trump secures $2 trillion in Gulf deals.
Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025 For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying opportunity.
Jim Cramer Says Even 'Safety' Stocks Look Risky, Warns Of 'Wild Card' In Washington And Rising Treasury Yields As Reasons To Stay Away From Sure Bets Rising bond yields and uncertain politics make 'safety' stocks less appealing, says Jim Cramer. Even Procter & Gamble and Johnson & Johnson suddenly feel shaky to the market guru.
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030 Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states.
CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26.
Trump Unveils 'Historic And Transformative' $600 Billion Saudi Deal, Predicts Markets Will 'Go A Lot Higher' President Trump unveils a $600 billion Saudi investment package into the U.S., with major deals in tech, defense, energy, and healthcare.
Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News It's biggest product will be up for price negotiations under the Inflation Reduction Act much sooner than expected.
Top S&P500 movers in Monday's pre-market session Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform It's still unclear how President Donald Trump plans to tie drug prices in the U.S. to international prices.
Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company...Ask Your PBM For A List Of Claims' Mark Cuban, the billionaire entrepreneur, challenged Trump-supporter and political activist Charlie Kirk's stance on high drug prices, asserting that Pharmacy Benefit Managers (PBMs) are the main culprits, not Big Pharma.
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the "most consequential executive order" in U.S. history, aimed at lowering prescription drug prices.
